Skip to content
POM-V Prescription Required

Ingelvac Ery Emulsion for Injection for Pigs

Active ingredient: Erysipelothrix rhusiopathiae

Form

Injection

Species

Pigs

Manufacturer

Laboratorios SYVA S.A.U

VMD MA No.

31592/3005

What it's used for

For the active immunisation of pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Erysipelothrix rhusiopathiae

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Ingelvac Ery Emulsion for Injection for Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

For the active immunisation of pigs to reduce clinical signs (skin lesions and fever) of
swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 2, as shown under
experimental challenge conditions in seronegative pigs.
Onset of immunity: 3 weeks after completion of the primary vaccination scheme.
Duration of immunity: 5 months
Intramuscular use.
Shake well before use and intermittently during the process of vaccination.
Administer one dose of 2 ml intramuscularly in the neck muscles to pigs from 12 weeks
of age according to the following scheme:
Primary vaccination scheme: two intramuscular injections of one dose, 4 weeks apart.
Revaccination scheme: one intramuscular injection of one dose at least every 5 months.

Revised: May 2025
AN: 00240/2025
Can be used for vaccination of pregnant animals, however if vaccinating according to
the primary vaccination scheme, administer the first dose prior to mating or
insemination.
None

Revised: May 2025
AN: 00240/2025
Very common adverse reactions:
Local redness can appear within 24 hours after the vaccination, which typically
resolves without any treatment in less than 10 days but occasionally may persist up
to 43 days.
Local temperature at the injection site can appear on the day of administration, which
spontaneously resolves within 24 hours, although occasionally may persist up to
31 days.
Local pain at the injection site can appear on the day of administration, which
typically resolves without any treatment before 4 days. Occasionally may persist up
to 33 days.
Mild to moderate swelling (occasionally ≥ 5.1cm) and nodules 5 cm) can appear
on the day of vaccination at the injection site, which typically resolve without any
treatment in less than 17 days but occasionally may persist up to 38 days (swelling)
or 69 days (nodules).

Revised: May 2025
AN: 00240/2025
A transient increase in body temperature (average 0.85 °C, maximum 2.45 °C) can
appear within 6 hours after vaccination, which spontaneously resolves within 24
hours without any known consequence to the health or productivity of the animal.
These reactions were observed under experimental and field conditions.
Common adverse reactions:
Transient apathy can appear within 6 hours after vaccination, which resolved without
treatment within 24 hours. This was observed under experimental and field conditions.
Hypersensitivity-like reactions, causing affected breathing and muscular stiffness,
which resolved without treatment in a few minutes, was observed in one field study.
Uncommon adverse reactions:
General swelling in the neck can appear within two days after vaccination, which
resolved without treatment within 13 days. This was observed under experimental and
field conditions.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Vaccinate healthy animals only

Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
To the user:
This veterinary medicinal product contains mineral oil. Accidental injection/self-
injection may result in severe pain and swelling, particularly if injected into a joint or
finger, and in rare cases could result in the loss of the affected finger if prompt
medical attention is not given. If you are accidentally injected with this veterinary
medicinal product, seek prompt medical advice even if only a very small amount is
injected and take the package leaflet with you. If pain persists for more than 12 hours
after medical examination, seek medical advice again.
To the physician:
This veterinary medicinal product contains mineral oil. Even if small amounts have
been injected, accidental injection with this product can cause intense swelling, which
may, for example, result in ischaemic necrosis and even the loss of a digit. Expert,
PROMPT, surgical attention is required and may necessitate early incision and
irrigation of the injected area, especially where there is involvement of finger pulp or
tendon.
People with known hypersensitivity to thiomersal should avoid contact with the
product.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by
case basis.
Store and transport refrigerated (2 C – 8 C).
Do not freeze.
Protect from light.
Store in the original package.
on the day of vaccination at the injection site, which typically resolve without any
treatment in less than 17 days but occasionally may persist up to 38 days (swelling)
or 69 days (nodules).

Revised: May 2025
AN: 00240/2025
A transient increase in body temperature (average 0.85 °C, maximum 2.45 °C) can
appear within 6 hours after vaccination, which spontaneously resolves within 24
hours without any known consequence to the health or productivity of the animal.
These reactions were observed under experimental and field conditions.
Common adverse reactions:
Transient apathy can appear within 6 hours after vaccination, which resolved without
treatment within 24 hours. This was observed under experimental and field conditions.
Hypersensitivity-like reactions, causing affected breathing and muscular stiffness,
which resolved without treatment in a few minutes, was observed in one field study.
Uncommon adverse reactions:
General swelling in the neck can appear within two days after vaccination, which
resolved without treatment within 13 days. This was observed under experimental and
field conditions.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
4.7 Use during pregnancy, lactation or lay
Can be used during pregnancy and lactation, in accordance with the
recommendations in SPC Section 4.9
4.8 Interaction with other medicinal products and other forms of interaction
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by
case basis.
4.9 Amounts to be administered and administration route
Intramuscular use.
Shake well before use and intermittently during the process of vaccination.
Administer one dose of 2 ml intramuscularly in the neck muscles to pigs from 12 weeks
of age according to the following scheme:
Primary vaccination scheme: two intramuscular injections of one dose, 4 weeks apart.
Revaccination scheme: one intramuscular injection of one dose at least every 5 months.

Revised: May 2025
AN: 00240/2025
Can be used for vaccination of pregnant animals, however if vaccinating according to
the primary vaccination scheme, administer the first dose prior to mating or
insemination.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
No information is available on the administration of an overdose of this vaccine.
4.11 Withdrawal period(s)
Zero days.
5. IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group: Inactivated bacterial vaccines for pigs, erysipelothrix.
ATCvet code: QI09AB03.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.